The approval of the first malaria treatment for newborns and young infants could lead to imminent widespread use in Africa, ...

In a historic move, Swissmedic has approved Coartem Baby, the first malaria treatment specifically for newborns and young ...

The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Medicare drug ...

The newly approved medication, Coartem Baby, is a combination of two antimalarials. It is a lower dose version of a tablet ...

Novartis shares climb on strong Cosentyx sales, franchise growth, and a new malaria drug approval despite political risks.

In the latest version of the malaria drug for babies, Coartem is dissolvable, including in breast milk and is even available ...

Basel: Novartis has received approval from Swissmedic for Coartem (artemether-lumefantrine) Baby, a first malaria medicine ...

Swissmedic approves Novartis’ Coartem Baby to treat malaria in newborns and young infants: Basel Thursday, July 10, 2025, 11:00 Hrs [IST] Novartis announced Coartem (artemether- ...

A new malaria treatment has been approved for newborns and infants under 11lbs, filling a major gap in care for some of the most vulnerable children.

Switzerland's medical products authority has granted the first approval for a malaria medicine designed for small infants, ...

Players in the health sector have commended the approval of the first-ever malaria drug for babies weighing less than five ...

Following the Swiss authorization, eight African nations that participated in a joint regulatory review process are now ...